查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991508

全球黴漿菌檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Mycoplasma Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 169 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計黴漿菌檢測市場將從 2025 年的 12.6466 億美元成長到 2034 年的 41.8459 億美元，2026 年至 2034 年的複合年成長率為 14.22%。

隨著生物技術和製藥行業日益重視產品安全和質量，全球黴漿菌檢測市場正在不斷擴大。黴漿菌是一種微小的細菌，會污染生物研究和製藥生產中使用的細胞培養。對實驗室和生產設施進行黴漿菌污染檢測至關重要，這有助於防止研究結果的可靠性受到影響，並避免生產出安全隱患的醫療產品。

市場成長主要受生物製藥產量增加和產品安全監管要求日益嚴格推動。製藥公司和研究機構依賴先進的檢測技術來快速且準確地檢測污染。分子診斷技術的進步提高了這些檢測的效率和靈敏度。

隨著生技研發的不斷拓展，黴漿菌檢測市場前景依然光明。自動化檢測系統和快速檢測方法的創新有望提高實驗室效率。此外，細胞療法和疫苗研發投入的增加預計將推動對可靠污染檢測技術的需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球黴漿菌檢測市場：依產品分類

  • 市場分析、洞察與預測
  • 裝置
  • 試劑盒和試劑
  • 服務

第5章：全球黴漿菌檢測市場：依技術分類

  • 市場分析、洞察與預測
  • PCR
  • ELISA
  • 直接檢測
  • 間接法
  • 微生物培養技術
  • 酵素法

第6章：全球黴漿菌檢測市場：依應用領域分類

  • 市場分析、洞察與預測
  • 細胞株檢測
  • 病毒檢測
  • 對已達到生產週期終點的細胞進行測試。
  • 其他

第7章：全球黴漿菌檢測市場：依最終用途分類

  • 市場分析、洞察與預測
  • 學術研究機構
  • 細胞庫
  • 受託研究機構
  • 製藥和生物技術公司
  • 其他

第8章：全球黴漿菌檢測市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Lonza Group AG
    • Merck KGaA
    • Charles River Laboratories International Inc
    • PromoCell GmbH
    • American Type Culture Collection
    • Asahi Kasei Medical Co. Ltd
    • Sartorius AG
    • InvivoGen
    • Eurofins Scientific
    • （ATCC）American Type Culture Collection
簡介目錄
Product Code: VMR11214398

The Mycoplasma Testing Market size is expected to reach USD 4184.59 Million in 2034 from USD 1264.66 Million (2025) growing at a CAGR of 14.22% during 2026-2034.

The global mycoplasma testing market has expanded as biotechnology and pharmaceutical industries focus on ensuring product safety and quality. Mycoplasma are small bacteria that can contaminate cell cultures used in biological research and drug production. Testing for mycoplasma contamination is essential in laboratories and manufacturing facilities to prevent compromised research results and unsafe medical products.

Market growth is driven by increasing biopharmaceutical production and stricter regulatory requirements for product safety. Pharmaceutical companies and research institutions rely on advanced testing technologies to detect contamination quickly and accurately. Improvements in molecular diagnostic methods have enhanced testing efficiency and sensitivity.

The future outlook for the mycoplasma testing market remains positive as biotechnology research continues to expand. Innovations in automated testing systems and rapid detection methods may improve laboratory productivity. Increasing investments in cell-based therapies and vaccine development are also expected to drive demand for reliable contamination testing technologies.

MARKET SEGMENTATION

By Product

  • Instruments
  • Kits & Reagents
  • Services

By Technology

  • PCR
  • ELISA
  • Direct Assay
  • Indirect Assay
  • Microbial Culture Techniques
  • Enzymatic Methods

By Application

  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others

By End-use

  • Academic Research Institutes
  • Cell Banks
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, Lonza Group AG, Merck KGaA, Charles River Laboratories International Inc, PromoCell GmbH, American Type Culture Collection, Asahi Kasei Medical Co Ltd, Sartorius AG, InvivoGen, Eurofins Scientific, ATCC American Type Culture Collection
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MYCOPLASMA TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MYCOPLASMA TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Direct Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Indirect Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Microbial Culture Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Enzymatic Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MYCOPLASMA TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Cell Line Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Virus Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. End of Production Cells Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MYCOPLASMA TESTING MARKET: BY END-USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-use
  • 7.2. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cell Banks Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MYCOPLASMA TESTING MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Technology
    • 8.2.3 By Application
    • 8.2.4 By End-use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Technology
    • 8.3.3 By Application
    • 8.3.4 By End-use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Technology
    • 8.4.3 By Application
    • 8.4.4 By End-use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Technology
    • 8.5.3 By Application
    • 8.5.4 By End-use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Technology
    • 8.6.3 By Application
    • 8.6.4 By End-use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MYCOPLASMA TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific Inc
    • 10.2.2 Lonza Group AG
    • 10.2.3 Merck KGaA
    • 10.2.4 Charles River Laboratories International Inc
    • 10.2.5 PromoCell GmbH
    • 10.2.6 American Type Culture Collection
    • 10.2.7 Asahi Kasei Medical Co. Ltd
    • 10.2.8 Sartorius AG
    • 10.2.9 InvivoGen
    • 10.2.10 Eurofins Scientific
    • 10.2.11 (ATCC) American Type Culture Collection